SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 13th, 2020 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 15, 2020 by and between Tauriga Sciences, Inc., a Florida corporation, with headquarters located at 555 Madison Avenue, 5th Floor, New York, NY 10022 (the “Company”), and ADAR ALEF, LLC, a New York limited liability company, with its address at 38 Olympia Ln, Monsey, NY 10952 (the “Buyer”).
2% FIXED CONVERTIBLE PROMISSORY NOTE OF TAURIGA SCIENCES, INC.Tauriga Sciences, Inc. • February 13th, 2020 • Medicinal chemicals & botanical products • Puerto Rico
This Note is a duly authorized Fixed Convertible Promissory Note of Tauriga Sciences, Inc., a corporation duly organized and existing under the laws of the State of Florida (the “Company”), designated as the Company’s 2% Fixed Convertible Promissory Note due August 6, 2020 (“Maturity Date”) in the face amount of $65,000 (the “Note”).
JOINT VENTURE PARTNERSHIP AGREEMENTJoint Venture Partnership Agreement • February 13th, 2020 • Tauriga Sciences, Inc. • Medicinal chemicals & botanical products • Florida
This JOINT VENTURE PARTNERSHIP AGREEMENT (“Agreement”) is made and executed on this 21 Day of January, 2020 by and between: OG LABRATORIES, LLC, a Florida Limited Liability Company (“Company”), and SETH SHAW, (Tauriga Sciences ).
